These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 30975989)

  • 1. Multi-region sequencing unveils novel actionable targets and spatial heterogeneity in esophageal squamous cell carcinoma.
    Yan T; Cui H; Zhou Y; Yang B; Kong P; Zhang Y; Liu Y; Wang B; Cheng Y; Li J; Guo S; Xu E; Liu H; Cheng C; Zhang L; Chen L; Zhuang X; Qian Y; Yang J; Ma Y; Li H; Wang F; Liu J; Liu X; Su D; Wang Y; Sun R; Guo S; Li Y; Cheng X; Liu Z; Zhan Q; Cui Y
    Nat Commun; 2019 Apr; 10(1):1670. PubMed ID: 30975989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
    Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
    Front Immunol; 2021; 12():669750. PubMed ID: 34054840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paired whole exome and transcriptome analyses for the Immunogenomic changes during concurrent chemoradiotherapy in esophageal squamous cell carcinoma.
    Park S; Joung JG; Min YW; Nam JY; Ryu D; Oh D; Park WY; Lee SH; Choi Y; Ahn JS; Ahn MJ; Park K; Sun JM
    J Immunother Cancer; 2019 May; 7(1):128. PubMed ID: 31097034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic and epigenomic evolution of acquired resistance to combination therapy in esophageal squamous cell carcinoma.
    Min Q; Wang Y; Wu Q; Li X; Teng H; Fan J; Cao Y; Fan P; Zhan Q
    JCI Insight; 2021 Sep; 6(17):. PubMed ID: 34494553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancer demethylation-regulated gene score identified molecular subtypes, inspiring immunotherapy or CDK4/6 inhibitor therapy in oesophageal squamous cell carcinoma.
    Gao W; Liu S; Wu Y; Wei W; Yang Q; Li W; Chen H; Luo A; Wang Y; Liu Z
    EBioMedicine; 2024 Jul; 105():105177. PubMed ID: 38924839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Molecular Analyses of Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, and Gastric Adenocarcinoma.
    Salem ME; Puccini A; Xiu J; Raghavan D; Lenz HJ; Korn WM; Shields AF; Philip PA; Marshall JL; Goldberg RM
    Oncologist; 2018 Nov; 23(11):1319-1327. PubMed ID: 29866946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic profiling of esophageal squamous cell carcinoma (ESCC)-Basis for precision medicine.
    Yang JW; Choi YL
    Pathol Res Pract; 2017 Jul; 213(7):836-841. PubMed ID: 28554745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive Exploration to Identify Predictive DNA Markers of ΔNp63/SOX2 in Drug Resistance in Human Esophageal Squamous Cell Carcinoma.
    Ooizumi Y; Kojima K; Igarashi K; Tanaka Y; Harada H; Yokota K; Kaida T; Ishii S; Tanaka T; Yokoi K; Nishizawa N; Washio M; Ushiku H; Katoh H; Kosaka Y; Mieno H; Hosoda K; Watanabe M; Katada C; Hiki N; Yamashita K
    Ann Surg Oncol; 2019 Dec; 26(13):4814-4825. PubMed ID: 31529309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic characterization of esophageal squamous cell carcinoma: Insights from next-generation sequencing.
    Sasaki Y; Tamura M; Koyama R; Nakagaki T; Adachi Y; Tokino T
    World J Gastroenterol; 2016 Feb; 22(7):2284-93. PubMed ID: 26900290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-153-3p regulates cell proliferation and cisplatin resistance via Nrf-2 in esophageal squamous cell carcinoma.
    Zuo J; Zhao M; Fan Z; Liu B; Wang Y; Li Y; Lv P; Xing L; Zhang X; Shen H
    Thorac Cancer; 2020 Mar; 11(3):738-747. PubMed ID: 32012470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic biomarker study in patients with clinical stage I esophageal squamous cell carcinoma: JCOG0502-A1.
    Oshima K; Kato K; Ito Y; Daiko H; Nozaki I; Nakagawa S; Shibuya Y; Kojima T; Toh Y; Okada M; Hironaka S; Akiyama Y; Komatsu Y; Maejima K; Nakagawa H; Onuki R; Nagai M; Kato M; Kanato K; Kuchiba A; Nakamura K; Kitagawa Y
    Cancer Sci; 2022 Mar; 113(3):1018-1027. PubMed ID: 34962019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic and transcriptional characterization of early esophageal squamous cell carcinoma.
    Zhao J; Jia X; Li Q; Zhang H; Wang J; Huang S; Hu Z; Li C
    BMC Med Genomics; 2023 Jul; 16(1):153. PubMed ID: 37393256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-region sequencing reveals genetic correlation between esophageal squamous cell carcinoma and matched cell-free DNA.
    Yuan Z; Wang X; Geng X; Li Y; Tan F; Xue Q; Gao S; He J
    Cancer Genet; 2021 Nov; 258-259():93-100. PubMed ID: 34688997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population and single‑cell transcriptome analyses reveal diverse transcriptional changes associated with radioresistance in esophageal squamous cell carcinoma.
    Wu H; Yu J; Kong D; Xu Y; Zhang Z; Shui J; Li Z; Luo H; Wang K
    Int J Oncol; 2019 Dec; 55(6):1237-1248. PubMed ID: 31638164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-faceted epigenetic dysregulation of gene expression promotes esophageal squamous cell carcinoma.
    Cao W; Lee H; Wu W; Zaman A; McCorkle S; Yan M; Chen J; Xing Q; Sinnott-Armstrong N; Xu H; Sailani MR; Tang W; Cui Y; Liu J; Guan H; Lv P; Sun X; Sun L; Han P; Lou Y; Chang J; Wang J; Gao Y; Guo J; Schenk G; Shain AH; Biddle FG; Collisson E; Snyder M; Bivona TG
    Nat Commun; 2020 Jul; 11(1):3675. PubMed ID: 32699215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated analysis of genomic and transcriptomic profiles identified a prognostic immunohistochemistry panel for esophageal squamous cell cancer.
    Yu Y; Li Z; Huang C; Fang H; Zhao F; Zhou Y; Pan X; Li Q; Zhuang Y; Chen L; Xu J; Wang W
    Cancer Med; 2020 Jan; 9(2):575-585. PubMed ID: 31793228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide copy number variation analysis identified ANO1 as a novel oncogene and prognostic biomarker in esophageal squamous cell cancer.
    Yu Y; Cao J; Wu W; Zhu Q; Tang Y; Zhu C; Dai J; Li Z; Wang J; Xue L; Zhen F; Liu J; Huang C; Zhao F; Zhou Y; Wen W; Pan X; Wei H; Zhu Y; He Y; Que J; Wang W; Luo J; Xu J; Chen L
    Carcinogenesis; 2019 Oct; 40(10):1198-1208. PubMed ID: 31050728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased Numb protein expression predicts poor clinical outcomes in esophageal squamous cell carcinoma patients.
    Liu Z; Luo C; Yang W; Wang K; Hu C; Zou J; Zhu H; Fu L; Nie J; Cheng C
    Cancer Biol Ther; 2018 Jan; 19(1):34-41. PubMed ID: 28095111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inter- and intratumor DNA methylation heterogeneity associated with lymph node metastasis and prognosis of esophageal squamous cell carcinoma.
    Teng H; Xue M; Liang J; Wang X; Wang L; Wei W; Li C; Zhang Z; Li Q; Ran X; Shi X; Cai W; Wang W; Gao H; Sun Z
    Theranostics; 2020; 10(7):3035-3048. PubMed ID: 32194853
    [No Abstract]   [Full Text] [Related]  

  • 20. Upregulation of miR-519 enhances radiosensitivity of esophageal squamous cell carcinoma trough targeting PI3K/AKT/mTOR signaling pathway.
    Zhang Y; Chen W; Wang H; Pan T; Zhang Y; Li C
    Cancer Chemother Pharmacol; 2019 Dec; 84(6):1209-1218. PubMed ID: 31529206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.